Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06551090 · ClinicalTrials.gov registry record · NA

Prediction of Anxiety and Memory State

A NA study of Anxiety and Epilepsy, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06551090: Recruiting NA study of Anxiety and Epilepsy, sponsored by Columbia University.

NCT06551090 is a NA study of Anxiety and Epilepsy that is actively recruiting participants, run by Columbia University. The registered enrollment target is 40 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06551090, a NA study of Anxiety and Epilepsy, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to look at how signals in the brain, body, and behavior relate to anxiety and memory function. This project seeks to develop the CAMERA (Context-Aware Multimodal Ecological Research and Assessment) platform, a state-of-the-art open multimodal hardware/software system for measuring human brain-behavior relationships. The R61 portion of the project is designed to develop the CAMERA platform, which will use multimodal, passive sensor data to predict anxiety-memory state in patients undergoing inpatient monitoring with intracranial electrodes for clinical epilepsy, as well as to build CAMERA's passive data framework and active data framework.

Primary Outcome

Use a multimodal machine learning model (EMANet ) to predict ≥1 EMA anxiety-memory state outcome (target) in held-out data at the population level. Mean absolute error will be the mean difference in absolute value of predicted EMA and actual EMA scores. A higher mean error represents a less accurate prediction. Prediction must use ≥2 different passive modalities, showing significantly better prediction accuracy than either of the modalities alone.

Interventions

  • OTHER CAMERA (Context-Aware Multimodal Ecological Research and Assessment)

Study Locations (1)

New York

  • Columbia University Irving Medical Center - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-07-23
Est. Completion 2026-12-01
Phase NA
Columbia University

958 total trials

What NCT06551090 shows while recruiting

NCT06551090 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (91% lower).

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which CAMERA (Context-Aware Multimodal Ecological Research and Assessment) is the first listed.

NCT06551090 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06551090 about?

NCT06551090 is a clinical study titled "Prediction of Anxiety and Memory State". The purpose of this study is to look at how signals in the brain, body, and behavior relate to anxiety and memory function. This project seeks to develop the CAMERA (Context-Aware Multimodal Ecological Research and Assessment) platform, a state-of-the-art open multimodal hardware/software system for...

What is the current status of trial NCT06551090?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-07-23. Estimated completion is 2026-12-01.

What conditions does trial NCT06551090 study?

This clinical trial studies the following conditions: Anxiety, Epilepsy, Memory.

What interventions are being tested in trial NCT06551090?

The interventions under investigation include: CAMERA (Context-Aware Multimodal Ecological Research and Assessment) (OTHER).

Who is sponsoring clinical trial NCT06551090?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06551090 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06551090's enrollment target sits among peer trials

40 266th of 364 higher than 83 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06551090, the US trial registry maintained by the National Library of Medicine. NCT06551090 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.